FDA/CDER - Testimony

This is a Comment on the Food and Drug Administration (FDA) Notice: Using Innovative Technologies and Other Conditions of Safe Use to Expand Drug Products Considered Nonprescription

For related information, Open Docket Folder  Docket folder icon


Comment

Testimony presented for March 22, 2012 FDA Public Meeting:

Attachments

 (28)

CHPA_Melville_Oral

View Attachment:
Authors: CDER
 

CHPA--slides

View Attachment:
Authors: CDER
 

AKER_slides

View Attachment:
Authors: CDER
 

Borroughs_LearnSomething_Slides

View Attachment:
Authors: CDER
 

Bradford_introslide

View Attachment:
Authors: CDER
 

Englander_slides

View Attachment:
Authors: CDER
 

Delfs_slides

View Attachment:
Authors: CDER
 

Francesco_Slides

View Attachment:
Authors: CDER
 

Grossman_Slides

View Attachment:
Authors: CDER
 

APHA_menighan_slides

View Attachment:
Authors: CDER
 

PSPC_Mitchell_slides

View Attachment:
Authors: CDER
 

Reilly_ASHP_Slides

View Attachment:
Authors: CDER
 

reitberg_slides

View Attachment:
Authors: CDER
 

Sander_slides

View Attachment:
Authors: CDER
 

AMPC_Schlaifer_SLides

View Attachment:
Authors: CDER
 

Schwarz_Slides

View Attachment:
Authors: CDER
 

Soller_SelfCareCollaboration_Slides

View Attachment:
Authors: CDER
 

SoloHealth FDA

View Attachment:
Authors: CDER
 

Smartcare_Tarino_Slides

View Attachment:
Authors: CDER
 

PharmacyEducationPerspectives_Vlasses_slides

View Attachment:
Authors: CDER
 

RHTP_Oral Statement

View Attachment:
Authors: CDER
 

Ducca_HDMA_Oral

View Attachment:
Authors: CDER
 

AMA_Fryhofer_Oral

View Attachment:
Authors: CDER
 

Lake_FAAN FAI Oral Statement

View Attachment:
Authors: CDER
 

ACAAI_Lannier_Oral

View Attachment:
Authors: CDER
 

Russell_NABP_Oral

View Attachment:
Authors: CDER
 

Schaefer_NCPA_Oral

View Attachment:
Authors: CDER
 

AANP_towers_Oral

View Attachment:
Authors: CDER
 

 
 
Comment Period Closed
May 7 2012, at 11:59 PM ET
ID: FDA-2012-N-0171-0015
Tracking Number: 80fe24ac

Document Information

Date Posted: Mar 27, 2012
Show More Details  

Submitter Information

Country: United States
Category: Drug Industry - C0022